Sawai Pharmaceutical Co. Ltd. | Mutual Funds
Mutual Funds that own Sawai Pharmaceutical Co. Ltd.
826,500
1.88%
-189,197
1.49%
10/31/2016
AZ Multi Asset - Institutional T
740,000
1.68%
160,000
1.25%
06/30/2017
Nomura Asset TOPIX ETF Fund (1306)
634,900
1.44%
10,000
0.05%
07/31/2018
Vanguard Total International Stock Index Fund
566,517
1.29%
21,700
0.01%
07/31/2018
Stichting Pensioenfonds ABP (Global Equity Portfolio)
476,125
1.08%
38,792
0.01%
03/31/2018
Government Pension Fund - Global (The)
361,841
0.82%
15,799
0%
12/31/2017
Nordea 1 - Stable Return Fund
336,400
0.76%
0
0.1%
07/31/2018
Daiwa Asset TOPIX Listed ETF (1305)
311,700
0.71%
7,200
0.05%
07/31/2018
Nikko Asset Listed Index TOPIX ETF (1308)
286,000
0.65%
0
0.05%
08/20/2018
Old Westbury Large Cap Strategies Fund
264,320
0.6%
59,800
0.08%
04/30/2018
| Address |
5-2-30 Miyahara
Osaka Osaka 532
Japan
|
|
Employees
|
- |
| Website |
http://www.sawai.co.jp |
| Updated |
07/08/2019 |
| Sawai Pharmaceutical Co., Ltd. engages in the manufacture and sale of prescription pharmaceutical products. Its products include cardiovascular drugs, antihyperlipidemic agents, diabetes, anticancer drugs, and over-the-counter drugs. The company was founded by Hanpei Sawai and Noyo Sawai on April 1, 1929 and is headquartered in Osaka, Japan. |
